These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 5620424)
1. [Electrocardiographic changes during the treatment with corticosteroids in patients with allergic nose diseases]. Lipson IuP Zh Ushn Nos Gorl Bolezn; 1967; 27(1):92-3. PubMed ID: 5620424 [No Abstract] [Full Text] [Related]
2. Role of steroids in the treatment of rhinosinusitis with and without polyposis. Fokkens W Clin Allergy Immunol; 2007; 20():241-50. PubMed ID: 17534055 [No Abstract] [Full Text] [Related]
3. Rhinological disorders in the elderly. Janzen VD J Otolaryngol; 1986 Aug; 15(4):228-30. PubMed ID: 3747017 [TBL] [Abstract][Full Text] [Related]
4. Effects of intramuscular depot-corticosteroid on the nasal mucosa in allergic rhinitis. Ashoor AA; Ahmed M Ann Allergy; 1982 Mar; 48(3):184-6. PubMed ID: 7065483 [TBL] [Abstract][Full Text] [Related]
6. Influence of treatment on the nose and/or the lungs. Pauwels R Clin Exp Allergy; 1998 Jun; 28 Suppl 2():37-40. PubMed ID: 9678825 [TBL] [Abstract][Full Text] [Related]
7. [Effects of systemic corticosteroids on expression of Eotaxin in nasal polyps]. Yang W; Shi W; Chen J; Tao Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Jan; 21(2):79-81. PubMed ID: 17438850 [TBL] [Abstract][Full Text] [Related]
8. Assessment of intranasal corticosteroid use in allergic rhinitis: benefits, costs, and patient preferences. Dupclay L; Doyle J Am J Manag Care; 2002 Sep; 8(13 Suppl):S335-40. PubMed ID: 12243450 [TBL] [Abstract][Full Text] [Related]
10. Allergic rhinitis: treatment based on patient profiles. Prenner BM; Schenkel E Am J Med; 2006 Mar; 119(3):230-7. PubMed ID: 16490466 [TBL] [Abstract][Full Text] [Related]
11. Approach to the evaluation and medical management of chronic rhinosinusitis. Hamilos DL Clin Allergy Immunol; 2007; 20():299-320. PubMed ID: 17534060 [TBL] [Abstract][Full Text] [Related]
12. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Woodworth BA; Joseph K; Kaplan AP; Schlosser RJ Otolaryngol Head Neck Surg; 2004 Nov; 131(5):585-9. PubMed ID: 15523430 [TBL] [Abstract][Full Text] [Related]
13. [Fluocinolone acetonide in intranasal topical therapy]. Serafini I Ann Laringol Otol Rinol Faringol; 1968; 67(4):590-609. PubMed ID: 5756408 [No Abstract] [Full Text] [Related]
14. [The practice guideline 'allergic and non-allergic rhinitis' (first revision) from the Dutch College of General Practitioners; a response from the perspective of otolaryngology]. de Vries N; Schmidt JT Ned Tijdschr Geneeskd; 2007 Oct; 151(41):2253-5. PubMed ID: 17987891 [TBL] [Abstract][Full Text] [Related]
15. The use of corticosteroids and ACTH in allergic diseases. Slavin RG Mo Med; 1967 Mar; 64(3):207-12. PubMed ID: 4292455 [No Abstract] [Full Text] [Related]
17. Amphotericin B nasal spray has no effect on nasal polyps. Helbling A; Baumann A; Hänni C; Caversaccio M J Laryngol Otol; 2006 Dec; 120(12):1023-5. PubMed ID: 16965642 [TBL] [Abstract][Full Text] [Related]
18. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Scadding GK; Durham SR; Mirakian R; Jones NS; Drake-Lee AB; Ryan D; Dixon TA; Huber PA; Nasser SM; Clin Exp Allergy; 2008 Feb; 38(2):260-75. PubMed ID: 18167126 [TBL] [Abstract][Full Text] [Related]
19. [Allergic diseases: progress in diagnosis and therapy. II. Approach to diagnosis and treatment. 2. New mode of application of anti-allergy preparations. 2) Adrenal cortex steroid preparations]. Sano Y Nihon Naika Gakkai Zasshi; 1993 Oct; 82(10):1648-52. PubMed ID: 8228462 [No Abstract] [Full Text] [Related]